Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.33 HKD 1.22%
Market Cap: 61.1B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

7
Current
8.3
Median
17.2
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
7
=
Enterprise Value
48.5B HKD
/
EBIT
6.4B CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
6.7
2-Years Forward
EV/EBIT
6.1
3-Years Forward
EV/EBIT
5.5

See Also

Discover More